know
extent
coextract
inhibitor
interfer
molecular
rna
diagnost
assay
utmost
import
qiaamp
viral
rna
mini
kit
magna
pure
automat
extractor
b
kingfish
c
nuclisen
easymag
rna
extract
system
evalu
extract
effici
copurif
inhibitor
stool
suspens
realtim
revers
transcriptas
polymeras
chain
reaction
rrtpcr
coliphag
spike
system
lysi
buffer
serv
extern
control
cycl
threshold
ct
determin
rna
extract
stool
suspens
contain
unknown
n
vari
amount
inhibitor
n
stool
suspens
latter
group
also
use
determin
whether
enteroviru
rrtpcr
inhibit
correl
specif
rna
extract
stool
suspens
spike
enteroviru
rna
extract
stool
suspens
spike
intact
enteroviru
extract
rrtpcr
inhibit
vari
rna
extract
differ
system
inhibit
note
first
rna
extract
second
extract
b
c
respect
furthermor
enteroviru
rrtpcr
inhibit
correl
rrtpcr
inhibit
ad
enteroviru
rna
viru
particl
conclus
rrtpcr
rna
good
predictor
inhibit
enteroviru
rna
extract
stool
suspens
easymag
perform
best
howev
four
extract
method
suitabl
provid
extern
control
identifi
problemat
sampl
citat
shulman
lm
hindiyeh
muhsen
k
cohen
mendelson
e
et
al
evalu
four
differ
system
extract
rna
stool
suspens
use
coliphag
exogen
control
rtpcr
inhibit
plo
one
diagnosi
enter
viral
infect
real
time
revers
transcript
polymeras
chain
reaction
rrtpcr
rna
extract
stool
suspens
complement
increasingli
replac
diagnosi
base
viral
isol
character
tissu
cultur
howev
interpret
result
alway
straightforward
sensit
rrtpcr
neg
impact
compound
present
clinic
sampl
may
partial
complet
inhibit
rt
andor
pcr
chemistri
potenti
inhibitor
might
incomplet
remov
stool
suspens
rna
extract
includ
hemoglobin
immunoglobulin
bilirubin
triglycerid
complex
polysaccharid
organ
phenol
compound
glycogen
fat
metabol
product
especi
patholog
condit
bacteria
veget
medic
anticoagul
drug
alcohol
ad
list
endogen
rrtpcr
inhibitor
exogen
inhibitor
extract
protocol
deterg
chelat
compound
guanidinium
hcl
presenc
inhibitori
compound
extract
rna
extent
inhibit
determin
semiquantit
rrtpcr
rna
templat
present
sampl
ad
prior
extract
introduc
rrtpcr
mix
natur
modifi
encapsul
coliphag
rna
one
sourc
protect
rna
use
noncompetit
extern
rna
templat
control
effici
remov
inhibitor
patient
sampl
may
relat
intrins
properti
method
use
extract
rna
studi
compar
four
commerci
rna
extract
system
effici
rna
isol
remov
inhibitor
stool
sampl
extract
system
qiaamp
viral
rna
mini
kit
manual
extract
use
silica
column
qiagen
inc
valencia
ca
usa
magna
pure
automat
extractor
magna
pure
lc
total
nucleic
acid
isol
kithigh
perform
automat
rna
extract
use
magnet
bead
roch
diagnost
usa
kingfish
thermo
electron
corpor
waltham
usa
semiautomat
extract
use
magnet
bead
ambion
magmax
viral
rna
isol
kit
ambion
inc
austin
tx
usa
nuclisen
easymag
biomerieux
marci
letoil
franc
semiautomat
extractor
use
magnet
bead
easymag
extract
kit
addit
effect
exogen
templat
control
measur
inhibitor
coextract
rna
stool
suspens
relev
valid
enteroviru
diagnost
rrtpcr
suspens
discuss
ninetythre
stool
suspens
extract
four
extract
system
spike
lysi
buffer
yield
similar
final
concentr
contribut
endogen
rna
rule
sinc
rna
amplifi
stool
suspens
upon
extract
protocol
exogen
omit
lysi
buffer
result
extract
procedur
assign
level
inhibit
shown
tabl
individu
valu
shown
fig
proport
sampl
inhibitor
vari
among
extract
method
rna
extract
extract
protocol
b
c
respect
contain
inhibitor
rrtpcr
median
interquartil
rang
iqr
reduct
ct
protocol
b
c
respect
final
number
sampl
inhibit
ct
extract
protocol
respect
friedman
test
indic
statist
signific
differ
coextract
inhibitor
rrtpcr
among
extract
protocol
use
order
challeng
perform
extract
system
exclud
inhibitor
rrtpcr
stool
sampl
level
inhibit
rang
singl
cycl
complet
inhibit
evalu
sampl
select
among
archiv
stool
sampl
previous
test
enteroviru
extract
qiaamp
viral
rna
mini
kit
suffici
number
sampl
high
intermedi
low
level
inhibitor
chosen
reanalysi
enabl
comparison
extract
procedur
level
inhibit
result
inhibit
sampl
extract
protocol
shown
fig
summar
level
inhibit
tabl
experi
number
sampl
inhibitor
differ
among
four
protocol
individu
sampl
amount
inhibit
vari
depend
extract
protocol
specif
inhibitor
present
sampl
prepar
protocol
b
c
respect
median
iqr
reduct
ct
level
protocol
b
c
respect
importantli
number
proport
sampl
inhibit
ct
also
vari
among
protocol
protocol
b
c
respect
friedman
test
indic
statist
signific
differ
coextract
inhibitor
rrtpcr
among
extract
protocol
use
differenti
rrtpcr
inhibit
due
presenc
inhibitor
rna
extract
variat
due
differ
effici
extract
rna
extract
sampl
inhibitor
spike
two
concentr
purifi
enteroviru
rna
fig
first
concentr
equival
r
equival
second
contain
fold
ct
enteroviru
rna
r
high
signific
differ
inhibit
rrtpcr
enteroviru
rrtpcr
note
equival
amount
enteroviru
rna
ad
extract
prepar
protocol
b
c
fig
part
howev
higher
amount
enteroviru
rna
ad
significantli
less
inhibit
enteroviru
rrtpcr
rrtpcr
extract
prepar
use
protocol
b
c
thu
decreas
rrtpcr
serv
measur
amount
inhibitor
rna
extract
extract
protocol
analysi
varianc
indic
signific
differ
inhibit
ct
enteroviru
rna
protocol
b
c
amount
enteroviru
rna
equival
wherea
significantli
less
inhibit
higher
amount
enterovir
rna
test
rna
extract
protocol
b
c
thirteen
stool
suspens
vari
amount
inhibitor
spike
intact
viru
concentr
adjust
yield
ct
equival
spike
suspens
reextract
parallel
four
method
except
extent
inhibit
enteroviru
rrtpcr
similar
inhibit
rrtpcr
fig
number
sampl
ct
inhibit
rrtpcr
also
ct
inhibit
enteroviru
rrtpcr
protocol
b
c
respect
analysi
varianc
fig
part
indic
signific
differ
pair
ttest
inhibit
rrtpcr
extern
control
ad
enteroviru
protocol
c
protocol
b
inhibit
rrtpcr
enteroviru
actual
significantli
higher
p
recoveri
enteroviru
rna
four
differ
protocol
equival
one
trend
pathogen
identif
increas
relianc
molecular
method
achiev
high
throughput
high
sensit
specif
result
clinic
relev
time
howev
low
pathogen
copi
number
ineffici
extract
incomplet
remov
inhibitor
reduc
sensit
specif
molecular
assay
among
clinic
sampl
stool
suspens
contain
wide
rang
materi
potenti
inhibit
rt
andor
pcr
chemistri
thu
import
develop
reliabl
method
determin
whether
inhibitor
present
nucleic
acid
prepar
directli
stool
suspens
appropri
intern
control
exist
wide
differ
eukaryot
prokaryot
composit
fecal
materi
patient
four
protocol
extract
rna
stool
sampl
compar
studi
four
commerci
extract
method
among
commonli
use
diagnost
laboratori
none
sampl
contain
rna
similarli
nonov
et
al
report
unusu
amount
rna
would
indic
prior
presenc
sampl
ad
stool
suspens
concentr
two
eightfold
less
use
studi
coliphag
thu
use
noncompetit
extern
control
absenc
human
clinic
sampl
better
extern
control
rrtpcr
plasmid
phage
dna
sinc
also
measur
effici
rt
reaction
ad
lysi
buffer
minim
sampl
manipul
increas
uniform
manual
semiautomat
extract
protocol
presenc
rrtpcr
inhibitor
evalu
extract
equal
volum
stool
suspens
elut
equal
volum
elut
buffer
extract
perform
parallel
elimin
storag
relat
differ
rna
assay
rrtpcr
run
minim
analyt
differ
absenc
stool
sampl
confirm
rrtpcr
rna
extract
easymag
rna
extract
system
use
lysi
buffer
without
exogen
extract
protocol
system
least
amount
sampl
inhibitor
chosen
increas
chanc
find
endogen
rna
stool
number
stool
suspens
rna
extract
inhibitor
rrtpcr
vari
rna
extract
protocol
randomli
chosen
stool
suspens
amount
inhibitor
rna
extract
individu
stool
suspens
also
vari
accord
extract
procedur
suggest
one
type
inhibitor
may
present
differ
procedur
differ
profici
exclud
stool
sampl
extract
kingfish
nuclisen
easymag
fewer
extract
inhibitor
qiaamp
found
procedur
similar
use
easymag
outperform
manual
extract
procedur
similar
qiagen
magna
pure
kingfisherlik
procedur
intermedi
contrast
fewer
find
major
differ
system
result
present
confirm
rna
extract
magnet
beadbas
system
contain
fewer
inhibitor
columnbas
system
number
sampl
inhibitor
low
first
group
sampl
sampl
use
compar
rna
extract
procedur
order
better
compar
four
extract
procedur
select
among
previous
test
sampl
suffici
number
archiv
stool
suspens
high
intermedi
low
level
inhibitor
extract
qiaamp
viral
rna
mini
kit
sampl
stool
suspens
reextract
parallel
four
protocol
evalu
inhibit
rrtpcr
kingfish
nuclisen
easymag
semi
better
qiaamp
viral
rna
mini
kit
magna
pure
automat
extractor
differ
extract
effici
might
least
import
inhibitor
hata
et
al
show
ad
separ
control
extract
amplif
perform
similar
analysi
ad
enteroviru
rna
rna
sampl
extract
intact
enteroviru
suspens
extract
inhibit
enteroviru
rrtpcr
correl
rrtpcr
inhibit
import
note
four
extract
protocol
yield
equival
amount
enteroviru
rna
enteroviru
ad
suspens
inhibit
rna
rrtpcr
sampl
equal
start
elut
volum
pattern
amount
enteroviru
rrtpcr
inhibit
similar
specif
suspens
regardless
whether
enteroviru
ad
extract
viral
rna
ad
reaction
mix
extract
impli
appar
decreas
amount
rna
rna
extract
rna
ad
lysi
buffer
primarili
due
failur
remov
inhibitor
present
particular
stool
suspens
standard
maximum
volum
could
extract
differ
procedur
ml
qiagen
ml
magna
pure
ml
kingfish
ml
easymag
effect
use
manufactur
recommend
volum
stool
suspens
evalu
present
studi
although
done
would
meant
depend
procedur
use
would
fold
increas
amount
endogen
inhibitor
start
volum
without
concomit
increas
extract
wash
elut
buffer
volum
other
shown
increas
start
volum
increas
coextract
inhibitor
final
rrtpcr
outcom
balanc
specif
templat
coextract
inhibitor
major
rrtpcr
assay
lower
limit
quantit
target
sequenc
per
reaction
ct
approxim
cycl
reaction
threefold
shift
upward
ct
due
presenc
inhibitor
would
still
posit
ie
specif
signal
would
still
detect
cycl
cap
recommend
major
rrtpcr
assay
two
ct
differ
within
statist
variat
may
occur
repeat
analys
rna
contrast
posit
signal
would
longer
detect
sixfold
shift
ct
would
produc
fals
neg
outcom
conclus
inhibit
complex
process
four
extract
method
suitabl
provid
extern
control
use
identifi
problemat
sampl
rrtpcr
rna
recov
coliphag
ad
lysi
buffer
rna
extract
system
good
predictor
inhibit
enterovir
rna
extract
stool
suspens
one
inhibitor
may
present
stool
suspens
ad
extract
effici
remov
differ
extract
protocol
correl
extent
rrtpcr
inhibit
enterovir
rrtpcr
inhibit
increas
invers
relat
amount
enterovir
rna
sampl
agreement
dreier
et
al
rrtpcr
inhibit
test
rna
sampl
stool
suspens
time
test
sinc
way
predict
advanc
whether
inhibitor
effici
remov
extract
remain
activ
cycl
frozen
storag
viral
rrtpcr
result
consid
quantit
result
rrtpcr
inhibit
ct
final
recommend
neg
viral
rrtpcr
result
sampl
inhibit
ct
rrtpcr
consid
invalid
altern
method
use
reassay
reextract
sampl
rna
dilut
retest
sampl
posit
result
enteroviru
rrtpcr
consid
valid
ethic
review
board
sheba
medic
center
tel
hashom
approv
studi
sampl
result
strip
link
person
detail
pertain
could
use
identifi
individu
patient
data
analyz
anonym
ethic
review
board
exempt
studi
requir
obtain
inform
consent
stool
suspens
n
prepar
routin
analysi
clinic
stool
sampl
sent
central
virolog
laboratori
cvl
chaim
sheba
medic
center
israel
use
evalu
effici
four
differ
rna
extract
system
exclud
inhibitor
rrtpcr
ninetythre
stool
sampl
contain
unknown
amount
rrtpcr
inhibitor
tabl
fig
remain
ninetytwo
stool
suspens
select
among
stool
suspens
archiv
sent
routin
enteroviru
analysi
tabl
fig
rna
archiv
suspens
extract
manual
qiaamp
viral
rna
mini
kit
rrtpcr
inhibit
level
known
rrtpcr
inhibitor
ct
found
sampl
nonrandom
subset
sampl
sampl
high
intermedi
low
level
inhibitor
chosen
reanalysi
would
suffici
number
sampl
comparison
level
inhibit
small
portion
fecal
matter
vortex
second
stool
suspens
buffer
ml
salin
glass
bead
sampl
ml
contain
mg
dihydrostreptomycin
u
penicillin
g
u
mycostatin
volum
vv
chloroform
sampl
suspens
clarifi
centrifug
min
store
use
natur
e
coli
rna
coliphag
atcc
stock
prepar
e
coli
top
nzycm
broth
describ
dreier
et
al
aliquot
stock
frozen
concentr
stock
thaw
serial
dilut
dilut
buffer
mm
nacl
mm
mgso
mm
tri
ph
wv
gelatin
ad
respect
extract
lysi
buffer
use
extract
procedur
use
amount
extern
control
templat
ad
lysi
buffer
adjust
give
ct
approxim
copiesml
rrtpcr
mix
upon
addit
ml
rna
rna
extract
clarifi
fecal
suspens
use
four
differ
commerci
protocol
sampl
extract
parallel
elimin
storag
relat
differ
extract
perform
accord
manufactur
instruct
except
rna
extract
ml
stool
suspens
four
protocol
addit
respect
suspens
buffer
reach
recommend
aqueou
volum
list
rna
store
pend
analysi
analys
see
fig
sampl
also
extract
protocol
except
exogen
omit
lysi
buffer
abi
prism
sequenc
detect
system
appli
biosystem
foster
citi
ca
usa
use
amplif
detect
enteroviru
rna
taqman
technolog
previous
describ
briefli
rrtpcr
ml
rna
ad
agpath
mastermix
ambion
appli
biosystem
inc
foster
citi
california
contain
publish
concentr
primer
probe
succinimidyl
ester
rox
intern
refer
dye
wherea
ml
rna
ad
enteroviru
rrtpcr
assay
rrtpcr
perform
follow
condit
min
min
cycl
min
rna
extract
stool
suspens
four
procedur
assay
rrtpcr
run
minim
analyt
differ
data
manag
analyz
use
excel
microsoft
spss
ver
softwar
extract
protocol
presenc
rel
amount
rrtpcr
inhibitor
determin
compar
rrtpcr
ct
result
obtain
absenc
presenc
stool
suspens
measur
ct
result
assign
one
five
level
inhibit
inhibit
inhibit
ct
fold
inhibit
ct
fold
inhibit
ct
fold
inhibit
ct
fold
similarli
presenc
rel
amount
inhibitor
enteroviru
rna
rrtpcr
determin
compar
enteroviru
rrtpcr
ct
result
obtain
absenc
presenc
stool
suspens
enteroviru
ad
extract
enteroviru
rna
ad
extract
inhibit
suspens
gave
ct
rrtpcr
suspens
buffer
alon
set
upper
limit
rrtpcr
inhibit
cap
ct
nonparametr
friedman
test
use
determin
determin
whether
signific
differ
result
among
four
differ
extract
protocol
posthoc
analysi
pairwis
differ
protocol
perform
use
wilcoxon
signedrank
test
spss
bonferroni
correct
set
signific
level
pairwis
comparison
comparison
rrtpcr
enterovir
rrtpcr
ct
repeat
measur
analysi
variant
figur
rrtpcr
inhibit
rna
extract
stool
suspens
use
four
differ
rna
extract
protocol
equal
amount
stool
suspens
chosen
randomli
among
sampl
sent
laboratori
extract
four
protocol
qiagen
b
magna
pure
c
kingfish
easymag
describ
method
coliphag
calcul
give
ct
rrtpcr
ad
extract
buffer
rrtpcr
valu
rna
extract
buffer
control
subtract
valu
rna
extract
stool
suspens
differ
number
ct
inhibit
shown
box
right
sampl
number
neg
valu
set
maximum
valu
inhibit
c
cap
ct
sampl
inhibit
ct
indic
color
box
black
red
tan
light
yellow
respect
blank
white
box
indic
inhibit
number
sampl
categori
signific
differ
shown
tabl
experi
pdf
figur
rrtpcr
inhibit
rna
extract
stool
refreez
thaw
extract
protocol
three
repeat
measur
rrtpcr
perform
sampl
protocol
qiagen
b
magna
pure
c
kingfish
easymag
describ
method
rna
store
test
coliphag
ad
extract
buffer
rrtpcr
valu
rna
extract
buffer
alon
subtract
valu
rna
extract
stool
suspens
differ
number
ct
inhibit
shown
box
right
sampl
number
neg
valu
set
maximum
valu
inhibit
c
cap
ct
sampl
inhibit
ct
indic
color
box
black
red
tan
light
yellow
respect
blank
white
box
indic
sampl
inhibit
sampl
store
measur
mean
three
repeat
test
squar
mean
sq
standard
deviat
run
sd
signific
differ
mean
repeat
measur
extract
protocol
present
signific
differ
repeat
measur
extract
protocol
friedman
test
valu
comparison
among
extract
method
signific
differ
among
extract
protocol
shade
yellow
box
wilcoxon
singedrank
test
spss
bonferroni
correct
signific
pairwis
comparison
mean
three
measur
rrtpcr
result
differ
extract
protocol
shade
yellow
box
indic
pairwis
differ
extract
protocol
signific
pdf
